Fiche société
Shenzhen MagicRNA Biotechnology Co., Ltd
Traitements, essais et publications liés.
Traitements3programmes
Essais3liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| HN2301 injectionThis is an open lable and single arm study, is designed to evaluate the safety and preliminary efficacy of HN2301 in Autoimmune Disease（AID） | Lupus, Myasthénie | Phase 1 | China | À vérifier | |
| HN2301 injectionThis is an open lable and single arm study, is designed to evaluate the safety and preliminary efficacy of HN2301 in Autoimmune Disease（AID） | Lupus | Phase 1 | China | À vérifier | |
| HN2301 injectionThis is an open lable and single arm study, is designed to evaluate the safety and preliminary efficacy of HN2301 in Autoimmune Disease（AID） | Myasthénie | Phase 1 | China | À vérifier |
Essais cliniques
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| HN2301 injection | Myasthénie | Phase 1 | NCT07556120 | Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) | NOT_YET_RECRUITING |
| HN2302 Injection | Lupus | Phase 1 | NCT07523282 | AID — Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases | NOT_YET_RECRUITING |
| HN2301 injection | Lupus | Phase 1 | NCT06801119 | SLE，SSc，RA — Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||